Hypothermia and surgery: Immunologic mechanisms for current practice

Annals of Surgery

Volumn 250, Issue 1, 2009, Pages 134-140

  Qadan, Motaz ^a,b   Gardner, Sarah A ^a   Vitale, David S ^a   Lominadze, David ^a   Joshua, Irving G ^a   Polk Jr , Hiram C ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BODY TEMPERATURE; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CYTOKINE RELEASE; FEMALE; HUMAN; HYPOTHERMIA; INNATE IMMUNITY; MALE; MONOCYTE; MORTALITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; VENOUS BLOOD;

BLOOD; HUMANS; HYPOTHERMIA; IMMUNITY, INNATE; INTRAOPERATIVE PERIOD; LIPOPOLYSACCHARIDES; SURGICAL PROCEDURES, OPERATIVE; TEMPERATURE;

EID: 68249119517     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181ad85f7     Document Type: Article

References (51)

1. Kluger MJ. Fever-its Biology, Evolution, and Function. Princeton, NJ: Princeton University Press; 1979.
2. Hasday JD, Fairchild KD, Shanholtz C. The role of fever in the infected host. Microbes Infect. 2000;2:1891-1904.
3. Kurz A. Thermal care in the perioperative period. Best Pract Res Clin Anaesthesiol. 2008;22:39-62.
4. Kurz A, Sessler DI, Lenhardt R; Study of Wound Infection and Temperature Group. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. N Engl J Med. 1996;334:1209-1215.
5. Frank SM, Fleisher LA, Breslow MJ, et al. Perioperative maintenance of normothermia reduces the incidence of morbid cardiac events: a randomized clinical trial. JAMA. 1997;277:1127-1134.
6. Luna GK, Maier RV, Pavlin EG, et al. Incidence and effect of hypothermia in seriously injured patients. J Trauma. 1987;27:1014-1018.
7. Schmied H, Kurz A, Sessler DI, et al. Mild hypothermia increases blood loss and transfusion requirements during total hip arthroplasty. Lancet. 1996;347:289-292.
8. Lenhardt R, Marker E, Goll V, et al. Mild intraoperative hypothermia prolongs postanesthetic recovery. Anesthesiology. 1997;87:1318-1323.
9. Carli F, Emery PW, Freemantle CA. Effect of peroperative normothermia on postoperative protein metabolism in elderly patients undergoing hip arthroplasty. Br J Anaesth. 1989;63:276-282.
10. Kurz A, Plattner O, Sessler DI, et al. The threshold for thermoregulatory vasoconstriction during nitrous oxide/isoflurane anesthesia is lower in elderly than in young patients. Anesthesiology. 1993;79:465-469.
11. Peng RY, Bongard FS. Hypothermia in trauma patients. J Am Coll Surg. 1999;188:685-696.
12. Polk HC Jr, Lopez-Mayor JF. Postoperative wound infection: a prospective study of determinant factors and prevention. Surgery. 1969;66:97-103.
13. Mahid SS, Polk HC Jr, Lewis JN, et al. Opportunities for improved performance in surgical specialty practice. Ann Surg. 2008;247:380-388.
14. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359-1367.
15. Allen DB, Maguire JJ, Mahdavian M, et al. Wound hypoxia and acidosis limit neutrophil bacterial killing mechanisms. Arch Surg. 1997;132:991-996.
16. Greif R, Akca O, Horn EP, et al. ; Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection. N Engl J Med. 2000;342:161-167.
17. Hopf HW, Hunt TK, West JM, et al. Wound tissue oxygen tension predicts the risk of wound infection in surgical patients. Arch Surg. 1997;132:997-1004.
18. Leijh PC, van den Barselaar MT, van Zwet TL, et al. Kinetics of phagocytosis of Staphylococcus aureus and Escherichia coli by human granulocytes. Immunology. 1979;37:453-465.
19. van Oss CJ, Absolom DR, Moore LL, et al. Effect of temperature on the chemotaxis, phagocytic engulfment, digestion, and O2 consumption of human polymorphonuclear leukocytes. J Reticuloendothel Soc. 1980;27:561-565.
20. Wenisch C, Narzt E, Sessler DI, et al. Mild intraoperative hypothermia reduces production of reactive oxygen intermediates by polymorphonuclear leukocytes. Anesth Analg. 1996;82:810-816.
21. Miles AA, Miles EM, Burke J. The value and duration of defence reactions of the skin to the primary lodgement of bacteria. Br J Exp Pathol. 1957;38:79-96.
22. Polk HC, Miles AA. The decisive period in the primary infection of muscle by Escherichia coli. Br J Exp Pathol. 1973;54:99-109.
23. Oehler R, Pusch E, Dungel P, et al. Glutamine depletion impairs cellular stress response in human leucocytes. Br J Nutr. 2002;87(suppl 1):S17-S21.
24. Hirohashi N, Morrison DC. Low-dose lipopolysaccharide (LPS) pretreatment of mouse macrophages modulates LPS-dependent interleukin-6 production in vitro. Infect Immun. 1996;64:1011-1015.
25. Turina M, Miller FN, Tucker CF, et al. Short-term hyperglycemia in surgical patients and a study of related cellular mechanisms. Ann Surg. 2006;243:845-851.
26. Ditschkowski M, Kreuzfelder E, Rebmann V, et al. HLA-DR expression and soluble HLA-DR levels in septic patients after trauma. Ann Surg. 1999;229:246-254.
27. Livingston DH, Appel SH, Wellhausen SR, et al. Depressed interferon gamma production and monocyte HLA-DR expression after severe injury. Arch Surg. 1988;123:1309-1312.
28. Polk HC Jr, George CD, Wellhausen SR, et al. A systematic study of host defense processes in badly injured patients. Ann Surg. 1986;204:282-299.
29. Hershman MJ, Cheadle WG, Wellhausen SR, et al. Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient. Br J Surg. 1990;77:204-207.
30. Hershman MJ, Cheadle WG, Kuftinec D, et al. An outcome predictive score for sepsis and death following injury. Injury. 1988;19:263-266.
31. Lekkou A, Karakantza M, Mouzaki A, et al. Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with community-acquired severe infections. Clin Diagn Lab Immunol. 2004;11:161-167.
32. Cheadle WG, Hershman MJ, Wellhausen SR, et al. HLA-DR antigen expression on peripheral blood monocytes correlates with surgical infection. Am J Surg. 1991;161:639-645.
33. Ardeshna KM, Pizzey AR, Devereux S, et al. The PI3 kinase, p38 SAP kinase, and NF-κB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells. Blood. 2000;96:1039-1046.
34. Dandona P, Aljada A, Mohanty P, et al. Insulin inhibits intranuclear nuclear factor κB and stimulates κB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? J Clin Endocrinol Metab. 2001;86:3257-3265.
35. van der Poll T, Keogh CV, Buurman WA, et al. Passive immunization against tumor necrosis factor-alpha impairs host defense during pneumococcal pneumonia in mice. Am J Respir Crit Care Med. 1997;155:603-608.
36. Beutler B, Milsark IW, Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science. 1985;229:869-871.
37. Tracey KJ, Fong Y, Hesse DG, et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature. 1987;330:662-664.
38. Arndt P, Abraham E. Immunological therapy of sepsis: experimental therapies. Intensive Care Med. 2001;27(suppl 1):S104-S115.
39. van der Poll T. Immunotherapy of sepsis. Lancet Infect Dis. 2001;1:165-174.
40. Fairchild KD, Viscardi RM, Hester L, et al. Effects of hypothermia and hyperthermia on cytokine production by cultured human mononuclear phagocytes from adults and newborns. J Interferon Cytokine Res. 2000;20:1049-1055.
41. Fairchild KD, Singh IS, Patel S, et al. Hypothermia prolongs activation of NF-κB and augments generation of inflammatory cytokines. Am J Physiol Cell Physiol. 2004;287:C422-C431.
42. Bozkurt B, Kribbs SB, Clubb FJ Jr, et al. Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation. 1998;97:1382-1391.
43. Kubota T, McTiernan CF, Frye CS, et al. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res. 1997;81:627-635.
44. Clowes GH Jr, O'Donnell TF Jr, Ryan NT, et al. Energy metabolism in sepsis: treatment based on different patterns in shock and high output stage. Ann Surg. 1974;179:684-696.
45. Kluger MJ, Kozak W, Conn CA, et al. The adaptive value of fever. Infect Dis Clin North Am. 1996;10:1-20.
46. Jiang Q, Cross AS, Singh IS, et al. Febrile core temperature is essential for optimal host defense in bacterial peritonitis. Infect Immun. 2000;68:1265-1270.
47. Pritchard MT, Wolf SF, Kraybill WF, et al. The anti-tumor effect of interleukin-12 is enhanced by mild (fever-range) thermal therapy. Immunol Invest. 2005;34:361-380.
48. Oehler R, Pusch E, Zellner M, et al. Cell type-specific variations in the induction of hsp70 in human leukocytes by feverlike whole body hyperthermia. Cell Stress Chaperones. 2001;6:306-315.
49. Ostberg JR, Repasky EA. Emerging evidence indicates that physiologically relevant thermal stress regulates dendritic cell function. Cancer Immunol Immunother. 2006;55:292-298.
50. Milani V, Noessner E. Effects of thermal stress on tumor antigenicity and recognition by immune effector cells. Cancer Immunol Immunother. 2006;55:312-319.
51. Peng JC, Hyde C, Pai S, et al. Monocyte-derived DC primed with TLR agonists secrete IL-12p70 in a CD40-dependent manner under hyperthermic conditions. J Immunother. 2006;29:606-615.